DMD and Duchenne muscular dystrophy: Exon skipping is the approach used by a series of ASO drugs to treat Duchenne muscular dystrophy (DMD), an X-linked condition where the affected gene, dystrophin (also abbreviated to DMD), has many exons (a maximum of 79) which are naturally combined in a great variety of functional splice variants [40].